ENTACOVER 1: Entecavir IP (1mg) - Advanced Therapy for Chronic Hepatitis B

May 08, 2024

ENTACOVER 1

Entecavir 1mg

ENTACOVER 1, containing 1mg of Entecavir IP per tablet, is a potent antiviral medication specifically formulated to treat chronic Hepatitis B infection. It is designed to suppress the virus, prevent its replication, and reduce the liver damage associated with the disease.

Composition and Mechanism ENTACOVER 1 features Entecavir, a nucleoside analogue that inhibits reverse transcription, DNA replication, and transcription in the viral replication process, making it highly effective against the Hepatitis B virus (HBV):

  • Entecavir IP (1mg): Directly interferes with the HBV's ability to replicate DNA, effectively reducing the viral load in the body.

Benefits of ENTACOVER 1

  • Potent Viral Suppression: Significantly lowers the amount of virus in the body, helping to halt the progression of the disease.
  • Reduced Risk of Liver Complications: By controlling viral replication, ENTACOVER 1 reduces the risk of severe liver complications such as cirrhosis and liver cancer.
  • Improved Liver Function: Patients often experience an improvement in liver function tests, indicating reduced liver inflammation.

Usage Instructions

ENTACOVER 1 is usually taken on an empty stomach, at least 2 hours before or after a meal, to maximize absorption. The exact dosage and duration of treatment depend on the patient's condition and response to therapy, as determined by a healthcare provider.

Side Effects and Considerations

While ENTACOVER 1 is generally well-tolerated, some patients may experience side effects such as headache, fatigue, dizziness, and nausea. It is essential to discuss any existing liver conditions, other medications being taken, and potential side effects with a healthcare provider.

Availability and Pricing

ENTACOVER 1 is available through prescription at pharmacies. Patients should consult their healthcare provider for specific pricing details and to obtain a prescription.

Conclusion

ENTACOVER 1 offers a robust treatment option for managing chronic Hepatitis B, with proven effectiveness in reducing viral load and improving liver health. Its targeted action makes it a preferred choice for many patients seeking to control this chronic condition effectively.

Disclaimer: ENTACOVER 1 should be used under the guidance of a healthcare professional. Regular monitoring through blood tests and liver function assessments is recommended to ensure the effectiveness of the treatment and to manage any adverse effects. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology.The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW

SHARE WITH